Epigenetic Modifiers in Cancer Metastasis

被引:2
|
作者
Hu, Die [1 ,2 ,3 ]
Zhao, Tianci [4 ,5 ]
Xu, Chenxing [3 ]
Pan, Xinyi [3 ]
Zhou, Zhengyu [1 ,2 ,6 ]
Wang, Shengjie [1 ,2 ,3 ,6 ]
机构
[1] Nanjing Med Univ, Kangda Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[2] Soochow Univ, Suzhou Med Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[3] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang 222000, Peoples R China
[4] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang 110122, Peoples R China
[5] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110122, Peoples R China
[6] Soochow Univ, Suzhou Med Coll, Lab Anim Ctr, Suzhou 215123, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
epigenetics; DNA methylation; histone methylation; non-coding RNAs; metastasis; ENHANCER REPROGRAMMING PROMOTES; BREAST-CANCER; NONCODING RNA; LUNG METASTASIS; MESSENGER-RNA; LIVER-DISEASE; CELL; METHYLATION; GROWTH; CHROMATIN;
D O I
10.3390/biom14080916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis is the primary cause of cancer-related death, with the dissemination and colonization of primary tumor cells at the metastatic site facilitated by various molecules and complex pathways. Understanding the biological mechanisms underlying the metastatic process is critical for the development of effective interventions. Several epigenetic modifications have been identified that play critical roles in regulating cancer metastasis. This review aims to provide a comprehensive summary of recent advances in understanding the role of epigenetic modifiers, including histone modifications, DNA methylation, non-coding RNAs, enhancer reprogramming, chromatin accessibility, and N6-methyladenosine, in metastasis-associated processes, such as epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion. In particular, this review provides a detailed and in-depth description of the role of crosstalk between epigenetic regulators in tumor metastasis. Additionally, we explored the potential and limitations of epigenetics-related target molecules in the diagnosis, treatment, and prognosis of cancer metastasis.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth
    Turner, Taylor B.
    Meza-Perez, Selene
    Londono, Angelina
    Katre, Ashwini
    Peabody, Jacelyn E.
    Smith, Haller J.
    Forero, Andres
    Norian, Lyse A.
    Straughn, J. Michael, Jr.
    Buchsbaum, Donald J.
    Randall, Troy D.
    Arend, Rebecca C.
    ONCOTARGET, 2017, 8 (27) : 44159 - 44170
  • [42] Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
    Yang, Yongyong
    Di Ruscio, Annalisa
    Inoue, Satoshi
    Wang, Guocan
    Gao, Shuai
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Epigenetic modifiers in normal and malignant hematopoiesis
    Haladyna, Jessica N.
    Yamauchi, Taylor
    Neff, Tobias
    Bernt, Kathrin M.
    EPIGENOMICS, 2015, 7 (02) : 301 - 320
  • [44] Epigenetic modifiers in normal and aberrent erythropoeisis
    Sundaravel, Sriram
    Steidl, Ulrich
    Wickrema, Amittha
    SEMINARS IN HEMATOLOGY, 2021, 58 (01) : 15 - 26
  • [45] SCREENING FOR AND CHARACTERISING MAMMALIAN EPIGENETIC MODIFIERS
    Chen, Kelan
    Hu, Jiang
    Moore, Darcy L.
    Liu, Ruijie
    Breslin, Kelsey
    Jansz, Natasha
    Kessans, Sarah A.
    Lucet, Isabelle S.
    Keniry, Andrew
    Leong, Huei San
    Parish, Clare L.
    Hilton, Douglas J.
    Lemmers, Richard J. L. F.
    van der Maarel, Silvere M.
    Czabotar, Peter E.
    Dobson, Renwick C.
    Ritchie, Matthew E.
    Kay, Graham F.
    Murphy, James M.
    Blewitt, Marnie E.
    JOURNAL OF GENE MEDICINE, 2015, 17 (8-9): : 181 - 182
  • [46] Epigenetic modifiers of islet function and mass
    De Jesus, Dario F.
    Kulkarni, Rohit N.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2014, 25 (12): : 628 - 636
  • [47] Epigenetic modifiers: catalytic or noncatalytic, that is the question
    Liu, Yimin
    Li, Haitao
    FRONTIERS OF MEDICINE, 2024, 18 (05) : 941 - 943
  • [48] Epigenetic Drugs As Modifiers of NHEJ Repair
    Robert, C.
    Gojo, I
    Rassool, F.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (07) : 704 - 704
  • [49] Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
    Burkitt, Kyunghee
    Saloura, Vassiliki
    CANCERS, 2021, 13 (20)
  • [50] RETRACTED: Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer (Retracted Article)
    Shi, Lin
    Zheng, Minghuan
    Hou, Jiayuan
    Zhu, Bijun
    Wang, Xiangdong
    SEMINARS IN CANCER BIOLOGY, 2017, 42 : 4 - 12